Document is current
Any future updates will be listed below
-
Authors
Guo, Xue
Xu, Jing
He, Hanchang
Huang, Chen
Li, Jianhong
Xu, Haoming
Liao, Yitong
Zhao, Yuchen
Jin, Na
Zhang, Leiting
Wang, Hong
Zhou, Youlian
Nie, Yuqiang
- License Information
-
More Information
Article History
Received: 2 June 2026
Accepted: 25 August 2026
First Online: 1 September 2026
Declarations
Ethics approval and consent to participate: The human study (Grant No.: S-2022-060) was approved by the Ethics Committee of the Second Affiliated Hospital of South China University of Technology (Guangzhou First People’s Hospital), with the requirement for informed consent waived due to its retrospective design. All animal experiments were approved by the Animal Ethics Committee of the Second Affiliated Hospital of South China University of Technology (IACUC of Daoke Pharmaceutical Technology (Guangdong) Co., Ltd., approval No.IACUC-DK-2022-08-01-01) and performed in strict accordance with the ARRIVE guidelines.
Consent for publication: Not applicable. This manuscript does not contain any individual person’s data in any form. All patient data were anonymized and de-identified prior to analysis.
Competing interests: The authors declare no competing interests.
